Drug comparisons
Canagliflozin vs Donislecel
Canagliflozin (Invokana) is an oral SGLT2i for T2D. Donislecel (Lantidra) is islet cell therapy for T1D with hypo unawareness. Different indications.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when researching the full range of diabetes treatments from daily oral drugs to advanced islet cell therapies.
Bottom line
Canagliflozin and Donislecel treat different diabetes types and are not interchangeable alternatives.
All medication comparisons